Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-13

Clinical Trial Update: Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population [Phase 2]

View source ↗

Summary

Phase 2 trial investigating anti-cancer activity of artichoke extract in individuals with asbestos exposure; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • artichoke extract (artichoke extract)

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Asbestos Exposure | Phase 2 | Status: COMPLETED